| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.191 | 38.819 | 36.779 | 31.138 | 28.065 | 9.489 | 22.034 | 26.544 | 31.774 | 33.774 |
| Total Income - EUR | 40.191 | 38.819 | 36.779 | 31.138 | 28.065 | 12.169 | 21.862 | 26.544 | 31.774 | 33.774 |
| Total Expenses - EUR | 41.109 | 39.981 | 35.429 | 29.395 | 28.380 | 13.228 | 20.859 | 26.917 | 31.651 | 33.458 |
| Gross Profit/Loss - EUR | -917 | -1.162 | 1.350 | 1.743 | -314 | -1.059 | 1.003 | -372 | 122 | 316 |
| Net Profit/Loss - EUR | -2.124 | -1.550 | 982 | 1.434 | -595 | -1.131 | 1.003 | -615 | -196 | -700 |
| Employees | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Roxy Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Current Assets | 4.506 | 2.330 | 1.620 | 1.890 | 1.420 | 1.862 | 2.659 | 2.111 | 1.567 | 1.219 |
| Inventories | 3.458 | 1.751 | 1.421 | 1.759 | 1.301 | 1.201 | 2.206 | 1.089 | 1.450 | 1.144 |
| Receivables | 1.012 | 445 | 0 | 0 | 0 | 605 | 0 | 802 | 0 | 0 |
| Cash | 35 | 134 | 199 | 131 | 119 | 55 | 452 | 220 | 117 | 75 |
| Shareholders Funds | -16.169 | -17.555 | -16.276 | -14.543 | -14.857 | -15.706 | 2.163 | 1.555 | 964 | 259 |
| Social Capital | 1.125 | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 20.743 | 19.952 | 17.962 | 16.498 | 16.340 | 17.630 | 556 | 616 | 664 | 1.020 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Roxy Med Srl